Repurposing dopamine D3 receptor fluorescent ligands for D2 receptor
Ots, K.; Laasfeld, T.; Hollo, K.; Ilisson, M.; Ortigueira Noya, S.; Grassl, F.; Tousi, D.; Allas, H.-R.; Majellaro, M.; Enkvist, E.; Heinrich, M. R.; Sotelo, E.; Allikalt, A.
Show abstract
The dopamine D2 receptor is a principal target of antipsychotic and antiparkinsonian drugs, yet well-characterized fluorescent ligands for the D2 receptor remain scarce compared with its relative, the D3 receptor. Here we show that fluorescent ligands developed for the D3 subtype can be repurposed as tools for studying the D2 receptor pharmacology. Using a machine-learning-assisted, live-cell fluorescence microscopy assay, we screened twelve fluorescent probes and identified eight ligands that bound specifically to the D2 receptor at 10 nM. Four ligands exhibited classical saturable binding, yielding Kd in the nanomolar range, whereas the remaining probes displayed unsaturated, time-dependent binding profiles. Kinetic analyses revealed substantial differences in association and dissociation behavior, highlighting the importance of time-resolved measurements. Competition binding with dopamine and haloperidol yielded affinity estimates consistent with literature values. These results expand the toolkit of validated D2 receptor fluorescent probes and support cross-receptor repurposing as a strategy for fluorescent ligand development.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exifone is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration 91%
- A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor 91%
- Structural Insights into Dopamine Receptor-Ligand Interactions: From Agonists to Antagonists 91%
Similar papers in this journal
- Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions 92%
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 92%
- Structure-activity relationship studies of three novel 4-aminopyridine K+ channel blockers 91%
Similar papers in this journal
- Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation 92%
- FDA drug repurposing uncovers modulators of dopamine D2 receptor localization via disruption of the NCS-1 interaction 92%
- Illuminating Dark Chemical Matter using the Cell Painting Assay 91%
Similar papers in this journal
- De-risking drug discovery of intracellular targeting peptides: screening strategies to eliminate false-positive hits 92%
- AI-Assisted Discovery and Optimization of Small Molecule TREM2 Agonists with Functional Microglial Activity 91%
- TMPRSS2 inhibitor discovery facilitated through an in silico and biochemical screening platform 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.